TerraTox - HIV-1 structure file, May 2004. Copyright ... - TerraBase Inc.

5210 C64H99N5O6 Indinavir-[Myr]2
5211 C66H75Cl2N9O24 Vancomycin
c1ncccc1CN2CCN([C@@H](C2)C(=O)NC(C)(C)C)C[C@@H](OC(=O)CCCCCCCCCCCCC)
C[C@@H](Cc3ccccc3)C(=O)N[C@@H]4[C@H](OC(=O)CCCCCCCCCCCCC)Cc5ccccc45
C7(OC1OC(C(O)C(O)C1OC2OC(C(O)[C@@](N)(C)C2)C)CO)=C9OC%10=CC=C(C(O)C(C(
=O)NC(CC(=O)N)C(=O)NC8C(=O)NC4C(=O)NC(C(=O)NC(C=3C=C(C=C(O)C=3C5=C(C=C
C4=C5)O)O)C(=O)O)C(O)C6=CC=C(C(Cl)=C6)OC7=CC8=C9)NC(=O)C(NC)CC(C)C)C=C%
10Cl 1404-90-6
5212 C73H95ClN10O26 Eremomycin
5213 C74H115N5O24 Indinavir-[PEG350]2
5214 C74H72CaN4O14S4
5215 C75H121N5O24
5216 C76H122N6O25
O=C6N[C@H](c1cc(O)cc(O)c1c2cc(ccc2/O)[C@@H]7NC(=O)[C@H]3NC(=O)[C@@H](NC(
=O)[C@H](NC(=O)[C@@H](CC(C)(C)[H])NC)[C@@](O)([H])c%11cc(/[Cl])C(Oc8cc3cc(Oc4
ccc(cc4)[C@@H](O[C@@H]5C[C@@](N)(C)[C@](O)([H])[C@@](C)([H])O5)[C@H]6NC7=
O)c8O[C@H]9O[C@H](CO)[C@](O)([H])[C@@](O)([H])[C@@H]9O[C@@H]%10C[C@@](
N)(C)[C@](O)([H])[C@@](C)([H])O%10)cc%11)CC(=O)N)C(=O)O 110865-90-2
c1ncccc1CN2CCN([C@@H](C2)C(=O)NC(C)(C)C)C[C@@H](OC(=O)CCC(=O)OCCOCCO
CCOCCOCCOCCOCCOC)C[C@@H](Cc3ccccc3)C(=O)N[C@@H]4[C@H](OC(=O)CCC(=
O)OCCOCCOCCOCCOCCOCCOCCOC)Cc5ccccc45
Acid Blue 5 calcium salt; Alphazurin A; C.I. 42052;
benzenemethanaminium, N-ethyl-N-(4-((4-
(ethyl(phenylmethyl)amino)phenyl)(5-hydroxy-2,4- c1ccccc1C/[N+](CC)=C2/C=C\C(C=C2)=C(c3ccc(cc3)[N+](CC)Cc4ccccc4)\c5cc(O)c(S(=O)(
disulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)- =O)[O-])cc5S(=O)(=O)[O-
,
].[Ca++].c1ccccc1C/[N+](CC)=C2/C=C\C(C=C2)=C(c3ccc(cc3)[N+](CC)Cc4ccccc4)\c5cc(O)
hydroxide, inner salt, calcium salt (2:1)
c(S(=O)(=O)[O-])cc5S(=O)(=O)[O-] 3374-30-9
Indinavir-PEG2000(8) [correct structure has additional
OCC groups, 44 in total]
Saquinavir-PEG2000 [correct structure has additional
OCC groups, 44 in total]
c1ncccc1CN2CCN([C@@H](C2)C(=O)NC(C)(C)C)C[C@@H](O)C[C@@H](Cc3ccccc3)C(=
O)N[C@@H]4[C@H](OC(=O)CCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
CCOCCOCCOCCOCCOCCOCCOC)Cc5ccccc45
c1cccc2ccc(nc12)C(=O)N[C@@H](C(=O)N)C(=O)N[C@@H](Cc3ccccc3)[C@H](OC(=O)CC
C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCC
OC)CN4C[C@@]5([H])CCCC[C@@]5([H])C[C@H]4C(=O)NC(C)(C)C
5217 C204H301N51O64
Pentafuside; DP-178; Enfuvirtide; synthetic peptide on
basis of HIV-1 gp41 transmembrane protein
O=C(N[C@]([H])(CCC(N)=O)C(=O)N[C@]([H])(CCC(O)=O)C(=O)N[C@@]([H])(CCCCN)C(=
O)N[C@@]([H])(CC(N)=O)C(=O)N[C@@]([H])(CCC(O)=O)C(=O)N[C@]([H])(CCC(N)=O)C(
=O)N[C@@]([H])(CCC(O)=O)C(=O)N[C@@]([H])(CC(C)(C)[H])C(=O)N[C@@]([H])( 159519-65-0
5218
C470H743N133O164S
4
Cyanovirin-N, peptide fragment from cyanobacterium
Nostoc ellipsosporum with anti-HIV-1activity, ~11-kDa --NA-- 184539-38-6